SGCE
Basic information
Region (hg38): 7:94524204-94656572
Previous symbols: [ "DYT11" ]
Links
Phenotypes
GenCC
Source:
- myoclonic dystonia 11 (Strong), mode of inheritance: AD
- myoclonus-dystonia syndrome (Supportive), mode of inheritance: AD
- myoclonic dystonia 11 (Definitive), mode of inheritance: AD
- myoclonic dystonia 11 (Strong), mode of inheritance: AD
- myoclonic dystonia 11 (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Dystonia 11, myoclonic | AD | Neurologic | Treatment with deep-brain stimulation may be beneficial | Musculoskeletal; Neurologic | 4434166; 11528394; 12325078; 12391346; 11912106; 12634861; 12821748; 12743249; 16240355; 15728306; 17101905; 16534121; 16227522; 18362280; 20301587; 20800530; 21220679; 21267590; 21825253; 22026499 |
ClinVar
This is a list of variants' phenotypes submitted to
- Myoclonic_dystonia_11 (576 variants)
- not_provided (151 variants)
- Inborn_genetic_diseases (46 variants)
- not_specified (21 variants)
- SGCE-related_disorder (12 variants)
- Myoclonus-dystonia_syndrome (2 variants)
- Movement_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SGCE gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003919.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 94 | 101 | ||||
| missense | 279 | 10 | 301 | |||
| nonsense | 28 | 39 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 67 | 13 | 81 | |||
| splice donor/acceptor (+/-2bp) | 18 | 10 | 30 | |||
| Total | 118 | 38 | 291 | 104 | 2 |
Highest pathogenic variant AF is 0.000081290826
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SGCE | protein_coding | protein_coding | ENST00000445866 | 12 | 70980 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0238 | 0.976 | 125707 | 0 | 23 | 125730 | 0.0000915 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.05 | 207 | 254 | 0.814 | 0.0000133 | 3014 |
| Missense in Polyphen | 64 | 96.282 | 0.66472 | 1165 | ||
| Synonymous | 0.0982 | 89 | 90.2 | 0.987 | 0.00000480 | 873 |
| Loss of Function | 3.38 | 8 | 26.9 | 0.297 | 0.00000154 | 302 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000289 | 0.0000289 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.000150 | 0.000149 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000980 | 0.0000980 |
| Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix.;
- Disease
- DISEASE: Dystonia 11, myoclonic (DYT11) [MIM:159900]: A myoclonic dystonia. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT11 is characterized by involuntary lightning jerks and dystonic movements and postures alleviated by alcohol. Inheritance is autosomal dominant. The age of onset, pattern of body involvement, presence of myoclonus and response to alcohol are all variable. {ECO:0000269|PubMed:11528394, ECO:0000269|PubMed:12402271, ECO:0000269|PubMed:15079037, ECO:0000269|PubMed:15258227, ECO:0000269|PubMed:16227522, ECO:0000269|PubMed:17853490, ECO:0000269|PubMed:18175340, ECO:0000269|PubMed:18362280, ECO:0000269|PubMed:19066193, ECO:0000269|PubMed:21796726}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.231
Intolerance Scores
- loftool
- 0.0924
- rvis_EVS
- -0.54
- rvis_percentile_EVS
- 20.54
Haploinsufficiency Scores
- pHI
- 0.423
- hipred
- Y
- hipred_score
- 0.758
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.558
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sgce
- Phenotype
- muscle phenotype; cellular phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- cell-matrix adhesion;muscle organ development
- Cellular component
- Golgi apparatus;cytoskeleton;plasma membrane;integral component of plasma membrane;dystrophin-associated glycoprotein complex;sarcoglycan complex;dendrite membrane;sarcolemma
- Molecular function